These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 10326864)

  • 1. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
    Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
    Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
    Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis.
    Budunova IV; Carbajal S; Kang H; Viaje A; Slaga TJ
    Mol Carcinog; 1997 Mar; 18(3):177-85. PubMed ID: 9115588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility to tumor progression in mouse skin carcinogenesis.
    Stern MC; Conti CJ
    Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983
    [No Abstract]   [Full Text] [Related]  

  • 8. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1alpha up-regulation in vivo by a potent carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) and control of DMBA-induced inflammatory responses.
    Li X; Eckard J; Shah R; Malluck C; Frenkel K
    Cancer Res; 2002 Jan; 62(2):417-23. PubMed ID: 11809690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis.
    Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH
    Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connexin expression in epidermal cell lines from SENCAR mouse skin tumors.
    Budunova IV; Carbajal S; Viaje A; Slaga TJ
    Mol Carcinog; 1996 Mar; 15(3):190-201. PubMed ID: 8597532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines.
    Chen Z; Colon I; Ortiz N; Callister M; Dong G; Pegram MY; Arosarena O; Strome S; Nicholson JC; Van Waes C
    Cancer Res; 1998 Aug; 58(16):3668-76. PubMed ID: 9721877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis.
    Gebhardt C; Breitenbach U; Tuckermann JP; Dittrich BT; Richter KH; Angel P
    Oncogene; 2002 Jun; 21(27):4266-76. PubMed ID: 12082614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
    Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
    Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1alpha expression in SENCAR mouse epidermis: implications in the prevention of stage I tumor promotion.
    Zhao J; Sharma Y; Agarwal R
    Mol Carcinog; 1999 Dec; 26(4):321-33. PubMed ID: 10569809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
    Gabay C; Porter B; Fantuzzi G; Arend WP
    J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
    Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
    J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
    Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
    Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.